US Patent Issued to REGENERON PHARMACEUTICALS on June 17 for "Therapeutic uses of anti-GITR antibodies" (New Jersey, New York, Washington Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,127, issued on June 17, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Therapeutic uses of anti-GITR antibodies" was invented by Robert Babb (River Edge, N.J.), Drew Dudgeon (Montvale, N.J.), Yu Huang (Ossining, N.Y.), Rosalynn Molden (Shoreline, Wash.), William Olson (Yorktown Heights, N.Y.), Matthew Sleeman (Yorktown Heights, N.Y.), Dimitris Skokos (New York) and Bei Wang (Hastings-on-Hudson, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR), compositions comprising the anti...